Drug intelligence / Profile preview

PRDX1-IN-1

Development stage
Preclinical
Lead developer
MedChemExpress
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

PRDX1-IN-1 is a potent and selective small-molecule inhibitor of Peroxiredoxin 1 (PRDX1), an antioxidant enzyme that is frequently overexpressed in various cancers and plays a role in maintaining redox homeostasis. Derived from celastrol-ligustrazine hybrid chemistry, the compound has an IC50 of 0.164 μM against PRDX1. By inhibiting the antioxidant activity of PRDX1, PRDX1-IN-1 promotes the intracellular accumulation of reactive oxygen species (ROS), which leads to the induction of apoptosis and the inhibition of cancer cell proliferation, migration, and invasion. Preclinical research has explored its potential in models of breast, esophageal, lung, and clear cell renal cell carcinoma. It is currently utilized primarily as a research reagent to study PRDX1 biology and as a lead compound for anticancer drug development.

Other names
CAS 2996096-63-8CAS2996096-63-8CAS-2996096-63-8
02

Targets

PRDX1 (Peroxiredoxin-1)

Beyond the preview

Go deeper on PRDX1-IN-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRDX1-IN-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call